Skip to main content

Table 1 Patient characteristics

From: Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease

  Controls (n = 44) MVP (all) (n = 80) MVP (No significant MR) (n = 34) “Borderline” (n = 13)
Age (y) 46 [38–57] 52 [40–63]* 50 [35–59] 51 [36–63]
Male 23 (52%) 37 (46%) 14 (41%) 7 (50%)
BSA (m2) 1.9 [1.7–2.1] 1.7 [1.6–2.0]* 1.7 [1.6–2.0]* 1.8 [1.6–1.9]*
Hypertension 18/42 (43%) 27/73 (37%) 10/31 (32%) 1/9 (11%)
Diabetes mellitus 5/42 (12%) 0/51 (0%) 0/23 (0%) 1/13 (13%)
Current or former smoker 13/42 (31%) 13/50 (26%) 6/23 (26%) 0/9 (0%)*
Dyslipidemia 12/42 (29%) 16/52 (31%) 7/23 (30%) 2/9 (22%)
Obesity 10/42 (23%) 6/80 (8%)** 3/34 (9%)* 0/13 (0%)*
Family history of MVP (%) 0/41 (0%) 5/73 (7%) 2/31 (6%) 0/9 (0%)
Dyspnea 12/41 (29%) 19/71 (27%) 7/31 (23%) 2/8 (25%)
Chest pain 9/41 (22%) 17/72 (24%) 7/32 (22%) 1/8 (13%)
Palpitations 17/41 (41%) 50/98 (51%) 18/31 (58%) 4/8 (50%)
Sinus rhythm 44/44 (100%) 78/78 (100%) 34/34 (100%) 13/13 (100%)
  1. BSA body surface area. MR mitral regurgitation. MVP mitral valve prolapse
  2. Values expressed as n (%) or medians [interquartile range]. *P Value < 0.05 versus controls. **P Value < 0.01 versus controls